Neuraxpharm Denmark ApS

CVR 45449688 · Private limited company (ApS) · Active · Very high risk

Neuraxpharm Denmark ApS is a Private limited company (ApS), founded on , based in Herlev. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 11.5% over the next 12 months, which is 8.2 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK 356k and a net result of DKK 316k. CEO: Johan Anders Magnus Wassén, Mark Anthony Slater.

Bankruptcy risk for Neuraxpharm Denmark ApS

11.5%
probability of bankruptcy within 12 months
Very high risk

8.2 × the average (1.41%) · higher risk than 97% of active Danish companies

Lowest riskHighest risk

Increases the risk

Moves in the last 2 years2 · bankruptcy rate 23.9%2.7×
Age (years)1 yrs · bankruptcy rate 21.6%2.5×
Published annual reports1 · bankruptcy rate 18.7%2.1×
Time since new CEO1 yrs · bankruptcy rate 16.2%1.8×
Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Time at current address< 0.5 yrs · bankruptcy rate 12.0%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Equity ratio40%–60% · bankruptcy rate 4.6%0.52×
Return on assets15%+ · bankruptcy rate 5.1%0.58×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Loss for the yearNo · bankruptcy rate 5.3%0.60×
Current ratio150%–200% · bankruptcy rate 5.4%0.61×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
45449688
Status
Active
Company type
Private limited company (ApS)
Founded
(1 years)
Address
c/o Azets Insight A/S, Lyskær 3C, 2.
2730 Herlev
Municipality
Herlev
Industry
Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr
Share capital
DKK 40k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 1
Missing annual reportNo
Negative equityNo
Equity ratio45.8%
Current ratio185%
Moves (last 2 years)2
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address190
Going-concern uncertaintyNo

Financials and key figures

Financial year2025
Gross profitDKK 405k
Net profitDKK 316k
EquityDKK 356k
Total assetsDKK 776k
Short-term debtDKK 421k
Tax owedDKK 89k
Avg. employees0

Latest annual report: Reporting class B · auditor's statement: No assurance.

Filed annual reports

Reporting periodPublishedDays after period end
25 Feb 2025 – 31 Dec 2025156

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOJohan Anders Magnus WassénCurrent
CEOMark Anthony SlaterCurrent
Owner (100%)Neuraxpharm Arzneimittel GmbHCurrent
FounderNeuraxpharm Arzneimittel GmbHCurrent

Address history (2 moves)

c/o Azets Insight A/S, Lyskær 3C, 2., 2730 Herlev
c/o ECIT Services A/S, Hørkær 12A, 1., 2730 Herlev
c/o Accura Advokatpartnerselskab, Alexandriagade 8, 2150 Nordhavn

Other companies at the same address

Similar companies in Herlev

Questions and answers about Neuraxpharm Denmark ApS

Has Neuraxpharm Denmark ApS gone bankrupt?

No, Neuraxpharm Denmark ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Neuraxpharm Denmark ApS?

Our model estimates a bankruptcy risk of 11.5% over the next 12 months (very high risk), which is 8.2 times the average for Danish companies.

Who is the CEO of Neuraxpharm Denmark ApS?

Johan Anders Magnus Wassén, Mark Anthony Slater are the CEOs of Neuraxpharm Denmark ApS.

When was Neuraxpharm Denmark ApS founded?

Neuraxpharm Denmark ApS was founded on 25 February 2025.

What is the equity of Neuraxpharm Denmark ApS?

Equity was DKK 356k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.